by rss feed | Dec 5, 2021 | EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS, News Feeds
The progression of the cell cycle in human pluripotent stem cells is coupled with the oscillation of the reactive oxygen species (ROS) level. The decrease in this level results in the disturbance of the regulation and progression of S-phase, which, in turn, cause the...
by rss feed | Dec 5, 2021 | EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS, News Feeds, Uncategorized
Reprogramming of normal fibroblasts to induced pluripotent stem cells is characterized by low efficiency due to the upregulation of tumor suppressors and reprogramming-induced senescence (RIS). Spy1 can be combined with classical pluripotency factors to override RIS...
by rss feed | Apr 9, 2021 | EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS, News Feeds
Schematic illustration of current study focusing on the effect of fluid shear stress on adherens junction proteins in murine embryonic stem cells. No shear stress in adherent culture retains β‐catenin in the adherens junction, whereas high shear stress in bioreactor...
by rss feed | Mar 6, 2021 | EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS, News Feeds
This study assessed the ability of pluripotent stem cell derived cone photoreceptors to engraft in an end‐stage mouse model of photoreceptor degeneration model and restore vision. Our data demonstrate that pluripotent stem cell derived cone precursors can engraft into...
by rss feed | Feb 23, 2021 | EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS, News Feeds
Proposed clinical grade method to make better genetically stable human iPSC for clinical applications. CYCLIN D1 generated human iPSC have significantly improved genomic stability than current clinical grade methods that use C‐MYC, and thus clinically advantageous to...
by rss feed | Feb 23, 2021 | EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS, News Feeds
Abstract A key challenge for clinical application of induced pluripotent stem cells (iPSC) to accurately model and treat human pathologies depends on developing a method to generate genetically stable cells to reduce long‐term risks of cell transplant therapy. Here,...